Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAAD MD MANSOOR

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1912260464
CMS profile
1400190
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$1,469.57

  • Reported across 34 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$359.46

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $329.46 12
Education $30.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $184.98 5
Medtronic, Inc. $38.26 2
SI-BONE, INC. $37.44 2
Inari Medical, Inc. $34.39 1
Alexion Pharmaceuticals, Inc. $30.00 1
Tris Pharma Inc $20.15 1
Exact Sciences Corporation $14.24 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $35.77 2
PY2019 $500.39 3
PY2020 $141.28 2
PY2021 $106.79 6
PY2022 $21.75 1
PY2023 $304.13 7
PY2024 $359.46 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $30.00 07/11/2024 Education Undisputed 01/23/2026 1093985803 CMS
AstraZeneca Pharmaceuticals LP $14.02 03/11/2024 Food and Beverage Undisputed 01/23/2026 1104468134 CMS
AstraZeneca Pharmaceuticals LP $16.45 03/28/2024 Food and Beverage Undisputed 01/23/2026 1105860620 CMS
AstraZeneca Pharmaceuticals LP $13.39 07/03/2024 Food and Beverage Undisputed 01/23/2026 1104779742 CMS
AstraZeneca Pharmaceuticals LP $120.56 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104644499 CMS
AstraZeneca Pharmaceuticals LP $20.56 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105292397 CMS
Exact Sciences Corporation $14.24 09/26/2024 Food and Beverage Undisputed 01/23/2026 1114771512 CMS
Inari Medical, Inc. $34.39 11/20/2024 Food and Beverage Undisputed 01/23/2026 1140136119 CMS
Medtronic, Inc. $22.17 02/05/2024 Food and Beverage Undisputed 01/23/2026 1119544415 CMS
Medtronic, Inc. $16.09 05/28/2024 Food and Beverage Undisputed 01/23/2026 1119544417 CMS
SI-BONE, INC. $22.10 04/16/2024 Food and Beverage Undisputed 01/23/2026 1120069341 CMS
SI-BONE, INC. $15.34 04/25/2024 Food and Beverage Undisputed 01/23/2026 1120069385 CMS
Tris Pharma Inc $20.15 09/09/2024 Food and Beverage Undisputed 01/23/2026 1147224768 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.